Blog - Page 1666 of 5718

FridayAug 28, 2020 9:49 am

Trxade Group, Inc. (NASDAQ: MEDS) Augments B2B Services with New Bundled, COVID-responsive Employee Wellness Package

Pharmaceutical supplies and services innovator Trxade Group Inc. has announced a new B2B resource that bundles telemedicine services that may prove particularly useful for companies during the ongoing pandemic period Trxade Group’s new Bonum+ platform combines the power of telehealth consultation, AI-driven COVID-19 risk assessment and streamlined personal protective equipment purchasing to help manage employees’ care and performance The company is an emerging web-based presence in the wellness market that builds trust and independent pharmacy purchasing power through drug pricing transparency The company has achieved more than 50 percent penetration among the nation’s approximately 22,000 independent pharmacies. Trxade Group (NASDAQ:…

FridayAug 28, 2020 9:38 am

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Announces Second Eye-Net Pilot with Japanese Multinational Company

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that its wholly owned subsidiary, Eye-Net Mobile Ltd., will start a pilot project with a multibillion, multinational Japanese electronics company to test its Eye-Net(TM) Protect cellular-based vehicle-to-everything (“V2X”) accident prevention solution. This is the second pilot project Foresight announced this month, following first with a multibillion global Japanese technology company to test Eye-Net Mobile's solution. “This second pilot project is a vote of confidence from another Japanese company that reinforces our market penetration strategy, targeting the smart devices and services market, including dashcams, head-up displays,…

ThursdayAug 27, 2020 2:36 pm

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) to Offer Esketamine for Treatment of Adults with MDD at Flagship Clinic

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), today announced that it is expanding its rapid-onset treatment service for major depressive disorder (“MDD”). According to the update, Champignon will offer esketamine for the treatment of adults with MDD at its flagship clinic, the Canadian Rapid Treatment Centre of Excellence (“CRTCE”), starting in September 2020. Declared a breakthrough treatment for depression by the US Food and Drug Administration (“FDA”), esketamine was approved by Health Canada for the treatment of MDD in May 2020. “The availability of esketamine at the CRTCE provides tremendous opportunity for adults across Canada affected by treatment-resistant depression…

ThursdayAug 27, 2020 1:02 pm

QualityStocksNewsBreaks – ISW Holdings Inc. (ISWH) Bit5ive Partnership Is ‘Big Deal for ISWH Shares’

ISW Holdings (OTC: ISWH), a global brand-management portfolio company with diverse partnerships, is entering a promising new space just in time for the revolution in turnkey crypto-mining solutions (http://ibn.fm/9ELRZ). A recent article discussing this covers a TradingView report that highlights the company’s opportunity and optimal timing through a recent collaboration it deems a “big deal for ISWH shares.” The piece reads, “ISW Holdings Inc. has entered the crypto-mining equipment industry by virtue of its recent joint venture partnership with Bit5ive LLC, a global top player in the space developing, running and selling what are known as ‘turnkey mining solutions.’ This is…

ThursdayAug 27, 2020 12:39 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) and TumorGenesis Advancing Path Toward Patient-Specific Treatments

Predictive Oncology (NASDAQ: POAI), together with its TumorGenesis subsidiary, has achieved significant breakthroughs in applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery. Earlier in June, TumorGenesis, which is developing a new rapid approach to growing tumors in the laboratory, sold its first order of unique ovarian cancer cell culture media to a New England-based university carrying out research within the sector (http://ibn.fm/lpsCk). A recent article discussing POAI and TumorGenesis reads, “Predictive Oncology focuses on building AI-driven predictive models of tumor drug response and outcomes from its database of drug-response and genomic profiles gathered from more than 150,000…

ThursdayAug 27, 2020 11:58 am

ISW Holdings (ISWH) Q2 Financial Report Shows 79% Increase in Sales, Continued Impressive Upward Trend

Recent investment article notes ISWH’s financial report shows “larger than forecast topline growth.” The report represents the fifth consecutive quarter of strong growth by ISWH. Strong forecast based on strong performance by company’s home health division, cryptocurrency mining joint venture. The recent Q2 ISW Holdings (OTC: ISWH) financial report (http://ibn.fm/AwEC6), which included operational performance data for the three months and six months ended June 30, 2020, “silence(d) the skeptics, with larger than forecast topline growth powered by an expanding home healthcare segment, which could be set to further advance as the company integrates its proprietary telehealth technology into the mix,” noted a…

ThursdayAug 27, 2020 10:30 am

QualityStocksNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) Announces Participation Schedule for September Investor Conferences

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the additive manufacturing industry, recently announced its plans to participate in investor conferences during the month of September 2020. According to the update, SGLB will participate in the LD 500 Virtual Investor Conference slated to take place from September 1-4, 2020, and the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020. Sigma Labs CEO Mark K. Ruport will host a virtual presentation and participate in one-on-one meetings, and management will highlight its recent contract award with Mitsubishi Heavy Industries and other end users in a…

ThursdayAug 27, 2020 10:22 am

Sugarmade (SGMD) Q3 Numbers Forecast to Hit $11 Million, Thanks to Investment in Cannabis Delivery Service

Company predicts BudCars will reach $650,000 monthly sales milestone; Q3 2020 numbers to top $11 million CEO expects extremely robust growth in July, August; new records across many metrics BudCars has seen steady improvement in almost every major metric Sugarmade Inc. (OTCQB: SGMD), a product and branding marketing company investing in operations and technologies with disruptive potential, has announced that it expects BudCars Cannabis Delivery Service to hit a $650,000 sales milestone in July (http://ibn.fm/LDXLJ). The company also predicts its Q3 2020 sales numbers will top $11 million. “We believe we have enough visibility and enough data in hand to forecast…

ThursdayAug 27, 2020 10:07 am

QualityStocksNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) VP Scheduled to Present During Prestigious LD 500 Virtual Event

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF), a B2B global vendor of next-generation, push-to-talk over cellular (“PTT”) devices and cellular booster systems, will be participating at the upcoming LD 500 Virtual Conference. The four-day gathering, slated for Sept. 1–4, 2020, and featuring some of the most prominent companies in the micro-cap world, is the most ambitious event yet for the LD event group. Siyata Mobile’s vice president of corporate development, Daniel Kim, will be presenting during the premiere event, held online for the first time. His 20-minute live presentation is scheduled for Friday, Sept. 4, at 6:20 a.m. PST (9:20 a.m.…

WednesdayAug 26, 2020 2:47 pm

QualityStocksNewsBreaks – Cybin Corp. Poised Amid Groundbreaking Decision to Allow Psilocybin Therapy

Cybin Corp., an exemplary Canada-based life-science company focused on the development of pharmaceutical-grade psilocybin products, appears ideally positioned to leverage a milestone moment. Canada’s Minister of Health, the Honourable Patty Hajdu, recently approved the use of psilocybin therapy in the end-of-life treatment of four Canadians battling incurable cancer (http://ibn.fm/0BUOU), and this groundbreaking decision bodes well for companies such as Cybin, which are operating in the sector. The approval marks the first known, legal medical exemption for psilocybin use in Canada since the compound became illegal in the country in 1974. A recent article discussing this anticipates more applications through the exemption…

Site Search

Company Search